Early-stage funding as the silent driver of success in cutting-edge science

Scientific outreach often focuses on the final milestone, that tangible result that grabs the headlines: a new drug, a revolutionary material, or an early diagnosis. However, behind each of those endpoints lies a lengthy and complex journey where initial decisions and funding opportunities make the...

Redirecting to full article...